|
Mouse model of infant acute megakaryocytic leukemia.
|
5K08CA111399-03
|
$134,379
|
Raffel, Glen
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Murine models of activated FLT3 receptor tyrosine kinase
|
5K08CA113434-02
|
$140,130
|
LEE, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Variation in Ara-C Pathway Genes and Treatment Outcomes in AML
|
1R21CA119142-01A1
|
$164,365
|
GOYAL, RAKESH
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
|
Novel Ceramide-based Chemotherapy for Acute Leukemia
|
5R01CA100895-04
|
$236,830
|
MAURER, BARRY
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Promoting Treatment Adherence in Adolescent Leukemia
|
1R01CA119162-01A1
|
$701,307
|
DROTAR, DENNIS
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Role of Nucleophosmin in FA-evolved Leukemia
|
5R01CA109641-04
|
$289,623
|
PANG, QISHEN
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Molecular Studies of Down Syndrome Leukemia
|
5R01CA111778-03
|
$231,698
|
PERENTESIS, JOHN
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
RhoH GTPase in Hematopoiesis and Cancer
|
5R01CA113969-03
|
$279,026
|
WILLIAMS, DAVID
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
GENETIC PREDICTORS OF LEUKEMIA THERAPY RESPONSE
|
5R01CA108862-03
|
$256,930
|
Aplenc, Richard
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
ROLE OF mTOR INHIBITORS AND IL7 IN LYMPHOID MALIGNANCIES
|
5K08CA104882-04
|
$138,672
|
BROWN, VALERIE
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
ANTINEOPLASTIC v LEUKEMOGENIC EPIPODOPHYLLOTOXIN EFFECTS
|
5R01CA077683-08
|
$266,610
|
Felix, Carolyn
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Determinants of Relapse Risk After BMT for ALL
|
1R01CA116660-01A2
|
$304,189
|
GRUPP, STEPHAN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
|
5R01CA102646-03
|
$308,531
|
GRUPP, STEPHAN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Development of CpG oligodeoxynucleotides as adjuvant chemotherapy for ALL
|
5R03CA123554-02
|
$80,108
|
Reid, Gregor
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
The Adverse Effect of Health on Personal Goal Pursuit in Adolescents with Cancer
|
5R03CA126337-02
|
$80,593
|
Schwartz, Lisa
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
PEDIATRIC CHTN--AIDS CANCER RESEARCH
|
3U01CA054021-15S2
|
$828,868
|
QUALMAN, STEPHEN
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Ethnic Differences in Survival after Childhood ALL
|
5R01CA096670-04
|
$485,753
|
BHATIA, SMITA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA033572-24S1
|
$61,920
|
KRONTIRIS, THEODORE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA033572-24S2
|
$103,852
|
KRONTIRIS, THEODORE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA033572-24
|
$2,274,248
|
KRONTIRIS, THEODORE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Minority Predoctoral Fellowship Program
|
5F31CA117055-03
|
$28,176
|
ORTIZ, SERINA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Roles and Regulation of p53
|
5P01CA087497-07
|
$1,583,080
|
Prives, Carol
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Mechanisms of T-Cell Leukemogenesis Induced by Notch1
|
1R01CA120196-01A1
|
$305,900
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S1
|
$124,531
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S3
|
$137,869
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S4
|
$232,326
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S5
|
$250,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-43
|
$11,526,509
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Molecular Pathways to Thymic Lymphoma and Leukemia
|
5P01CA109901-04
|
$1,958,333
|
LOOK, A
|
DANA-FARBER CANCER INSTITUTE
|
|
Leukemogenic Slug Pathway in Hematopoietic Cell Survival
|
5R01CA059571-14
|
$405,347
|
LOOK, A
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA023108-29
|
$3,012,185
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Biochemistry of Leukemia Virus Core Binding Factor
|
5R01CA058343-14
|
$405,444
|
SPECK, NANCY
|
DARTMOUTH COLLEGE
|
|
Deficits in Facial Expression Recognition in Childhood Cancer Survivors
|
1R03CA128472-01
|
$92,338
|
BONNER, MELANIE
|
DUKE UNIVERSITY
|
|
TRICCS: Targeting Inattention in Childhood Cancer Survivors
|
1R03CA132570-01
|
$78,000
|
Hardy, Kristina
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-33S1
|
$84,062
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
5P30CA014236-33
|
$6,558,287
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Mechanisms of Leukemogenic Transformation by MLL-CALM
|
5R01CA109281-04
|
$262,921
|
WECHSLER, DANIEL
|
DUKE UNIVERSITY
|
|
Functions of E2A in B Lymphocyte Development
|
5R01CA072433-10
|
$310,291
|
Zhuang, Yuan
|
DUKE UNIVERSITY
|
|
EORTC DATA CENTER
|
5U10CA011488-37
|
$417,479
|
Sylvester, Richard
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
Pediaric Oncology Research Training Program
|
2T32CA009351-29
|
$237,038
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Biology and Prognostic implications of Flt3 mutations in AML
|
5R01CA114563-03
|
$421,364
|
MESHINCHI, SOHEIL
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Regional Oncology Research Center
|
3P30CA006973-45S1
|
$231,549
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-45S2
|
$126,362
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-45
|
$7,564,613
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Minimal Residual Disease in Pediatric ALL in Relation to Other Prognostic Factors
|
5R01CA086011-07
|
$542,666
|
BOROWITZ, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Developing FLT3-Targeted Therapy for Pediatric Leukemia
|
5K23CA111728-02
|
$140,130
|
BROWN, PATRICK
|
JOHNS HOPKINS UNIVERSITY
|
|
Bone Marrow Transplantation in Human Disease
|
2P01CA015396-32A1
|
$2,857,642
|
JONES, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
Glucocorticoid Receptor Regulation in Leukemia
|
1R01CA116042-01A2
|
$242,820
|
VEDECKIS, WAYNE
|
LOUISIANA STATE UNIV HSC NEW ORLEANS
|
|
Molecular genetics of MLL-associated leukemia
|
3P01CA105049-03S1
|
$127,761
|
DIAZ, MANUEL
|
LOYOLA UNIVERSITY CHICAGO
|
|
Molecular genetics of MLL-associated leukemia
|
5P01CA105049-03
|
$1,166,954
|
DIAZ, MANUEL
|
LOYOLA UNIVERSITY CHICAGO
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|